Clinical studies recruiting near Surprise

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Renal Pelvic Denervation Pilot Trial
NA · Panoramic Health / Southwest Kidney Institute, PLC · Verve Medical, Inc · NCT07005050 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Southwest Kidney Institute · Boehringer Ingelheim · NCT06531824 Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · Arizona Center for Cancer Care-Surprise · NRG Oncology · NCT06532279 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Southwest Kidney Institute · Boehringer Ingelheim · NCT07220083 A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Phase 3 · Panoramic Health - Southwest Kidney Institute, PLC · Takeda · NCT06963827 A Study to Evaluate Solrikitug in Participants With COPD (ZION)
Phase 2 · Uniquity One (UNI) · NCT06496620 Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Phase 3 · Emvera Health at Peak Heart & Vascular Surprise · Eli Lilly and Company · NCT07223593 CCM OPEN HF Registry
Phase N/A · Peak Heart and Vascular · Impulse Dynamics · NCT07112924 A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Alb
Phase 2 · Research Site · AstraZeneca · NCT07222917 Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pM
Phase 2/Phase 3 · Southwest Kidney Institute, PLC (SKI) - Surprise · Vertex Pharmaceuticals Incorporated · NCT07204275 High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Che
Phase 3 · Arizona Center for Cancer Care-Surprise · Alliance for Clinical Trials in Oncology · NCT06992427 MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Innovative Surgery Center · Stryker Instruments · NCT03072927 A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Dia
Phase 3 · Research Site · AstraZeneca · NCT07662135 Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Con
Phase 3 · Epic Medical Research - Surprise- Site Number : 8400096 · Sanofi · NCT07190209 Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Phase 3 · Arizona Center for Cancer Care-Surprise · NRG Oncology · NCT06958328 Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Phase 3 · Southwest Kidney Institute - Surprise · Eli Lilly and Company · NCT07157774 A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA
Phase 3 · Sunrise Medical Management LLC · Hoffmann-La Roche · NCT05797610 Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
Phase 2 · Research Site · AstraZeneca · NCT06824987 A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Co
Phase 3 · Research Site · AstraZeneca · NCT06742723 A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Phase 4 · Southwest Kidney Institute · Amgen · NCT06072482

Look up another city

Look up another condition